A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)
一项随机、安慰剂对照试验评估了lebrikizumab对未控制哮喘患者气道嗜酸性粒细胞炎症和重塑的影响（CLAVIER）
期刊:Clinical and Experimental Allergy
影响因子:5.2
doi:10.1111/cea.13731
Austin, Cary D; Gonzalez Edick, Melissa; Ferrando, Ronald E; Solon, Margaret; Baca, Miriam; Mesh, Kathryn; Bradding, Peter; Gauvreau, Gail M; Sumino, Kaharu; FitzGerald, J Mark; Israel, Elliot; Bjermer, Lief; Bourdin, Arnaud; Arron, Joseph R; Choy, David F; Olsson, Julie K; Abreu, Francis; Howard, Monet; Wong, Kit; Cai, Fang; Peng, Kun; Putnam, Wendy S; Holweg, Cécile T J; Matthews, John G; Kraft, Monica; Woodruff, Prescott G
